Copyright Reports & Markets. All rights reserved.

Global Pemphigus Vulgaris Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Pemphigus Vulgaris Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Oral
      • 1.4.3 Injectable
    • 1.5 Market by Application
      • 1.5.1 Global Pemphigus Vulgaris Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Retail Pharmacies
      • 1.5.4 Online Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Pemphigus Vulgaris Treatment Market Size
    • 2.2 Pemphigus Vulgaris Treatment Growth Trends by Regions
      • 2.2.1 Pemphigus Vulgaris Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Pemphigus Vulgaris Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Pemphigus Vulgaris Treatment Market Size by Manufacturers
      • 3.1.1 Global Pemphigus Vulgaris Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Pemphigus Vulgaris Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Pemphigus Vulgaris Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Pemphigus Vulgaris Treatment Key Players Head office and Area Served
    • 3.3 Key Players Pemphigus Vulgaris Treatment Product/Solution/Service
    • 3.4 Date of Enter into Pemphigus Vulgaris Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Pemphigus Vulgaris Treatment Market Size by Type (2014-2019)
    • 4.2 Global Pemphigus Vulgaris Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Pemphigus Vulgaris Treatment Market Size (2014-2019)
    • 5.2 Pemphigus Vulgaris Treatment Key Players in United States
    • 5.3 United States Pemphigus Vulgaris Treatment Market Size by Type
    • 5.4 United States Pemphigus Vulgaris Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Pemphigus Vulgaris Treatment Market Size (2014-2019)
    • 6.2 Pemphigus Vulgaris Treatment Key Players in Europe
    • 6.3 Europe Pemphigus Vulgaris Treatment Market Size by Type
    • 6.4 Europe Pemphigus Vulgaris Treatment Market Size by Application

    7 China

    • 7.1 China Pemphigus Vulgaris Treatment Market Size (2014-2019)
    • 7.2 Pemphigus Vulgaris Treatment Key Players in China
    • 7.3 China Pemphigus Vulgaris Treatment Market Size by Type
    • 7.4 China Pemphigus Vulgaris Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Pemphigus Vulgaris Treatment Market Size (2014-2019)
    • 8.2 Pemphigus Vulgaris Treatment Key Players in Japan
    • 8.3 Japan Pemphigus Vulgaris Treatment Market Size by Type
    • 8.4 Japan Pemphigus Vulgaris Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Pemphigus Vulgaris Treatment Market Size (2014-2019)
    • 9.2 Pemphigus Vulgaris Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Pemphigus Vulgaris Treatment Market Size by Type
    • 9.4 Southeast Asia Pemphigus Vulgaris Treatment Market Size by Application

    10 India

    • 10.1 India Pemphigus Vulgaris Treatment Market Size (2014-2019)
    • 10.2 Pemphigus Vulgaris Treatment Key Players in India
    • 10.3 India Pemphigus Vulgaris Treatment Market Size by Type
    • 10.4 India Pemphigus Vulgaris Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Pemphigus Vulgaris Treatment Market Size (2014-2019)
    • 11.2 Pemphigus Vulgaris Treatment Key Players in Central & South America
    • 11.3 Central & South America Pemphigus Vulgaris Treatment Market Size by Type
    • 11.4 Central & South America Pemphigus Vulgaris Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Roche
      • 12.1.1 Roche Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Pemphigus Vulgaris Treatment Introduction
      • 12.1.4 Roche Revenue in Pemphigus Vulgaris Treatment Business (2014-2019)
      • 12.1.5 Roche Recent Development
    • 12.2 Novartis
      • 12.2.1 Novartis Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Pemphigus Vulgaris Treatment Introduction
      • 12.2.4 Novartis Revenue in Pemphigus Vulgaris Treatment Business (2014-2019)
      • 12.2.5 Novartis Recent Development
    • 12.3 GlaxoSmithKline
      • 12.3.1 GlaxoSmithKline Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Pemphigus Vulgaris Treatment Introduction
      • 12.3.4 GlaxoSmithKline Revenue in Pemphigus Vulgaris Treatment Business (2014-2019)
      • 12.3.5 GlaxoSmithKline Recent Development
    • 12.4 Mylan
      • 12.4.1 Mylan Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Pemphigus Vulgaris Treatment Introduction
      • 12.4.4 Mylan Revenue in Pemphigus Vulgaris Treatment Business (2014-2019)
      • 12.4.5 Mylan Recent Development
    • 12.5 Genentech
      • 12.5.1 Genentech Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Pemphigus Vulgaris Treatment Introduction
      • 12.5.4 Genentech Revenue in Pemphigus Vulgaris Treatment Business (2014-2019)
      • 12.5.5 Genentech Recent Development
    • 12.6 Principia Biopharma
      • 12.6.1 Principia Biopharma Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Pemphigus Vulgaris Treatment Introduction
      • 12.6.4 Principia Biopharma Revenue in Pemphigus Vulgaris Treatment Business (2014-2019)
      • 12.6.5 Principia Biopharma Recent Development
    • 12.7 Argenx
      • 12.7.1 Argenx Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Pemphigus Vulgaris Treatment Introduction
      • 12.7.4 Argenx Revenue in Pemphigus Vulgaris Treatment Business (2014-2019)
      • 12.7.5 Argenx Recent Development
    • 12.8 Alexion
      • 12.8.1 Alexion Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Pemphigus Vulgaris Treatment Introduction
      • 12.8.4 Alexion Revenue in Pemphigus Vulgaris Treatment Business (2014-2019)
      • 12.8.5 Alexion Recent Development
    • 12.9 Vifor Pharma
      • 12.9.1 Vifor Pharma Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Pemphigus Vulgaris Treatment Introduction
      • 12.9.4 Vifor Pharma Revenue in Pemphigus Vulgaris Treatment Business (2014-2019)
      • 12.9.5 Vifor Pharma Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Pemphigus vulgaris is a rare chronic blistering skin disease and the most common form of pemphigus.
      In 2018, the global Pemphigus Vulgaris Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Pemphigus Vulgaris Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pemphigus Vulgaris Treatment development in United States, Europe and China.

      The key players covered in this study
      Roche
      Novartis
      GlaxoSmithKline
      Mylan
      Genentech
      Principia Biopharma
      Argenx
      Alexion
      Vifor Pharma

      Market segment by Type, the product can be split into
      Oral
      Injectable

      Market segment by Application, split into
      Hospital Pharmacies
      Retail Pharmacies
      Online Pharmacies

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Pemphigus Vulgaris Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Pemphigus Vulgaris Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Pemphigus Vulgaris Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now